COVID-19 Causes Astrogliosis, Long-Term Brain Inflammation and Cellular Damage

Medical News: The Unseen Battle Inside the Brain
Scientists have long suspected that COVID-19, caused by the SARS-CoV-2 virus, may have a more profound impact on the brain than previously understood. While the disease is primarily associated with respiratory issues, growing evidence suggests it can also lead to neurological complications. A groundbreaking study conducted by researchers from the University of Liège in Belgium has now uncovered compelling evidence that SARS-CoV-2 can infect brain cells, leading to inflammation and long-term damage. This Medical News report delves into their findings and what they mean for those who have recovered from COVID-19 but continue to experience lingering cognitive and neurological symptoms.


COVID-19 Causes Astrogliosis, Long-Term Brain Inflammation and Cellular Damage

The Study and Its Approach
To understand how SARS-CoV-2 affects the brain, the research team created long-term human cortical organoids - miniature, lab-grown models of the human brain developed from stem cells. These organoids were cultivated for six months to closely mimic the human brain’s cellular environment. Scientists then exposed them to SARS-CoV-2 and closely monitored how the virus interacted with different types of brain cells. Their goal was to determine which cells were most vulnerable to infection and what the downstream consequences of this infection were.
 
Their findings were striking. While the virus did not infect the majority of brain cells at high levels, it still managed to infiltrate specific populations, including astrocytes, deep projection neurons, upper callosal neurons, and inhibitory neurons. Among these, astrocytes were found to be the most vulnerable, showing the highest infection rates. This revelation is crucial, as astrocytes play a vital role in maintaining brain health, providing structural and metabolic support to neurons, and regulating inflammation.
 
How SARS-CoV-2 Alters Brain Function
The study revealed that infected astrocytes underwent significant changes. The cells exhibited morphological alterations, including swelling and structural disorganization. More importantly, the infection triggered an increase in the expression of key inflammation-related genes such as SERPINA3, CD44, and S100A10. These genes are known to be associated with astrogliosis - a condition where astrocytes become hyperactive, leading to chronic inflammation in the brain. This type of inflammation is often seen in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
 
In addition to inflammation, the infected cells also displayed upregulation of genes related to cell survival, such as SOD2. While this response might suggest that brain cells are attempting to protect themselves from damage, the persistence of these changes over time could contribute to long-term neurological dysfunction.
 
The Broader Implications for COVID-19 Survivors
One of the most significant takeaways from this study is the potential link between SARS-CoV-2 infe ction and long-term neurological symptoms experienced by COVID-19 survivors. Many individuals who have recovered from COVID-19 report lingering issues such as brain fog, memory problems, headaches, dizziness, and even psychiatric symptoms like anxiety and depression. Given that SARS-CoV-2 can cause sustained inflammation and cellular alterations in the brain, these findings provide a possible biological explanation for such symptoms.
 
Interestingly, the study found no direct evidence that the virus itself causes widespread cell death in the brain. Instead, it appears to trigger a chronic state of inflammation and cellular stress, which could contribute to the long-term symptoms seen in some patients. This aligns with emerging research suggesting that long COVID may be, at least in part, an inflammatory condition affecting multiple organs, including the brain.
 
Could SARS-CoV-2 Set the Stage for Future Neurological Disorders
Another pressing question raised by these findings is whether SARS-CoV-2 infection could increase the risk of developing neurodegenerative diseases later in life. Since the study demonstrated that infected astrocytes exhibit changes similar to those seen in conditions like Alzheimer’s, it raises concerns that even mild COVID-19 infections could have long-term consequences on brain health. While this hypothesis requires further investigation, it underscores the need for long-term monitoring of COVID-19 survivors, particularly those who experience persistent neurological symptoms.
 
What Can Be Done to Mitigate the Risks
While the full implications of these findings are still being explored, there are several steps that individuals and healthcare professionals can take to mitigate potential neurological effects of COVID-19.
 
-Early Detection and Monitoring: People recovering from COVID-19, especially those with neurological symptoms, should undergo regular health check-ups to monitor for any signs of cognitive decline or other neurological issues.
 
-Anti-Inflammatory Interventions: Since the study highlights the role of inflammation in SARS-CoV-2-related brain damage, researchers are exploring the potential use of anti-inflammatory drugs to help mitigate these effects.
 
-Lifestyle Modifications: Engaging in brain-healthy activities such as regular exercise, a balanced diet rich in anti-inflammatory foods, and stress management techniques may help protect brain function in the long run.
 
-Further Research: Scientists are now looking into whether vaccines or antiviral treatments might help reduce the neurological impact of SARS-CoV-2 by limiting the virus’s ability to infect brain cells.
 
Conclusion
The discovery that SARS-CoV-2 can infect astrocytes and trigger widespread inflammation in the brain provides new insight into the neurological complications of COVID-19. While the infection itself does not appear to cause large-scale brain cell death, the long-term activation of inflammatory and survival pathways suggests that COVID-19 may have lasting effects on brain function. This research highlights the need for continued studies on the long-term neurological impact of COVID-19 and underscores the importance of ongoing monitoring and support for individuals experiencing persistent cognitive and neurological symptoms.
 
As the world continues to grapple with the long-term effects of the pandemic, studies like this play a crucial role in understanding how COVID-19 affects the brain and in developing strategies to mitigate its impact.
 
The study findings were published in the peer-reviewed journal: Stem Cells.
https://academic.oup.com/stmcls/advance-article/doi/10.1093/stmcls/sxaf010/8086416
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/mild-or-moderate-covid-19-causes-accelerated-brain-aging-especially-in-young-to-early-middle-aged-adults
 
https://www.thailandmedical.news/news/researchers-warn-that-sars-cov-2-is-triggering-neurodegenerative-diseases-like-parkinsons
 
https://www.thailandmedical.news/news/study-reveals-alarming-connection-between-disruption-of-brain-waste-clearance-and-long-covid-symptoms
 
https://www.thailandmedical.news/pages/thailand_doctors_listings